Studies show similar pregnancy rates for both Clomiphene Citrate (Clomid) and Letrozole (Serophene), generally around 10-15% per cycle. However, success hinges on individual factors.
For women with Polycystic Ovary Syndrome (PCOS), some research suggests a slight edge for Letrozole, potentially leading to higher ovulation rates. This difference isn’t always significant, though, and depends on other contributing factors.
Age significantly impacts outcomes. Younger women generally experience better success rates with both medications. For women over 35, success rates decline noticeably, regardless of the drug used.
Duration of infertility also plays a role. Longer periods of infertility may reduce the chances of conceiving with either Clomid or Letrozole.
Underlying health conditions can affect response. Conditions like endometriosis or tubal damage may decrease pregnancy chances irrespective of the medication chosen.
Finally, response varies individually. What works for one woman may not work for another. A doctor’s guidance is vital for tailoring treatment to your specific circumstances and tracking progress.
